原发性肝癌合并糖尿病患者的介入治疗  

The efficacy of interventional treatment in patients with primary hepatic carcinoma complicated with diabetes mellitus

作　　者：马新明[1] 王敬忠[1] 

机构地区：[1]湖北省襄樊市中心医院介入室,襄樊市441021

出　　处：《实用医学影像杂志》2002年第2期119-121,共3页Journal of Practical Medical Imaging

摘　　要：目的评价原发性肝癌合并糖尿病患者介入治疗效果。方法本组12例患者,2例经肝动脉灌注化疗(TAC),10例加用栓塞(TACE)。结果除1例于治疗后3天死于肝昏迷外,其余11例治疗后血糖、尿糖水平得到有效控制,生存期超过1年者7例,2年者3例,3年者1例。结论经肝动脉灌注化疗+栓塞对原发性肝癌合并糖尿病具有明显疗效。Objective To assess the efficacy of interventional treatment in patients with primarry hepatic carcinoma complicated with diabetes mellitus.Methods Among 12 cases in this group 2 cases underwent transhepatic artery-infusion chemotherapy(TAC),10 cases underwent additional embolization(TACE).Results Except one case died of hepatic coma at third day after the treatment,the hyperglycemia and melituria in other eleven cases were effectively controlled to the pretherapeutic levels and their survival times were extended more than 1 to 3 years.Conclusion TACE is now an effective means in the treatment of patients with primary hepatic carcinoma complicated diabetes mellitus.

关 键 词：原发性肝癌 糖尿病 并发症 经肝动脉灌注化疗 栓塞术 介入治疗 

分 类 号：R735.7[医药卫生—肿瘤] R587.1[医药卫生—临床医学]